Research published in JAMA Network Open shows an increase in the proportion of African American patients screened in the first nine months after the USPTF 2021 Lung Cancer Screening Guidelines took effect.
The FDA authorized the InspectIR COVID-19 Breathalyzer -- the first COVID test that detects chemical compounds in breath samples associated with a SARS-CoV-2 infection.
To enable practitioners to resume testing in a safe and responsible manner, Vitalograph is offering a free trial pack of bacterial viral filters (BVF) to every clinic conducting spirometry tests.
Bronchoscopy plays a role in both diagnosis and treatment of lung disease and recent advances in the procedure have greatly enhanced the usefulness of the fiberoptic bronchoscope.
Read More
Werfen has received FDA 510(k) clearance for its GEM Hemochron 100 whole blood hemostasis system, which will be commercialized in the US in early 2022.
Read More
Acoustic tools can create microbubbles in the blood that are capable of changing in response to oxygen and signifying oxygen levels, according to a study presented at the 181st Meeting of the Acoustical Society of America.
Read More
The successful implementation of transcutaneous CO2 equipment at Hershey Medical Center’s Level IV NICU demonstrates that the technology has evolved to accommodate the diagnostic monitoring needs of neonatal care providers and patients, according to this case study by clinicians in the center’s NICU.
Read More
A new guideline from the American Thoracic Society recommends the use of fractional exhaled nitric oxide (FeNO) in patients with asthma in whom treatment is being considered.
Read More
Research on recovering COVID-19 patients has shown a considerable prevalence of altered diffusing capacity of the lung for carbon monoxide (DLCO) percentage in survivors.
Read More
The FDA has issued an emergency use authorization for the Acon Laboratories Flowflex COVID-19 Home Test, an over-the-counter COVID-19 antigen test.
Read More
The tools and best practices for handling infection control during pulmonary function testing have evolved and changed for the better during the pandemic.
Read More
Siemens Healthineers has developed the Atellica COVID-19 Severity Algorithm, a model designed to help predict the potential likelihood of progression to severe disease and life-threatening multiorgan dysfunction in COVID-19 patients.
Read More
The US FDA has issued clearance for Cognita Labs’ PulmoScan, the first at-home lung assessment device that measures airway resistance and elastance.
Read More
The US FDA has cleared the Siemens Naeotom Alpha, the world’s first photon-counting computed tomography (CT) scanner.
Read More
Six biomarkers identified in the breath of children infected with SARS-CoV-2 could potentially be used to screen for the virus using a breathalyzer.
Read More